Your bladder cancer has not reached the muscle layer of the bladder wall. This kind of cancer still comes back often, so you will get cystoscopies on a schedule for years. The goal is to keep your bladder and to catch any return early.
Recurrence means a new tumor of about the same kind. Progression means the cancer reaches a deeper layer or a higher grade. Most non-muscle-invasive cancers come back at some point, and far fewer ever progress. Your risk group tells you which is more likely for you.
After your first surgery (TURBT, or transurethral resection of bladder tumor), your team sorts your case into one of three risk groups. They look at stage, grade, tumor size, number of tumors, and whether you have CIS (carcinoma in situ). Your group sets which bladder medicine you get and how often you are scoped.
Surgery through the urethra to scrape out the tumor. Same-day or one-night stay. Gives the tissue diagnosis and is the first treatment.
For low and many intermediate cases, one dose of mitomycin or gemcitabine goes into the bladder within 24 hours of TURBT. It lowers the chance of an early new tumor by about a third.
A second TURBT 4 to 6 weeks later. About 1 in 3 to 1 in 2 high-grade T1 cases have leftover disease. About 1 in 10 are upstaged to muscle-invasive.
BCG is the long-time first choice for high risk. Mitomycin, gemcitabine, or gemcitabine plus docetaxel are options, especially with BCG in short supply.
Six weekly doses up front (induction), then three weekly doses at 3, 6, 12, 18, 24, 30, and 36 months. Up to three years total for high-risk cases.
Burning, frequency, and urgency for 1 to 2 days after each dose. Low-grade fever and tiredness are common.
Only one US maker. Your team may use a split dose (one vial across two or three patients) or a different bladder drug. Gemcitabine plus docetaxel has comparable response rates, and mitomycin has decades of data behind it.
Your temperature goes over 100.4 F. Shaking chills, joint pain, or a rash start up. You feel very unwell in the 24 to 48 hours after a dose. This is rare, and it is treated quickly.
How often you are scoped depends on your risk group. Low risk: 3 months, then 6 to 9 months, then yearly. Intermediate: every 3 to 6 months for 2 years, then every 6 to 12 months, then yearly out to about 10 years. High risk: every 3 months for 2 years, every 6 months through year 5, then yearly, often for life. A CT or MR urogram checks the kidneys and ureters every 1 to 2 years. Each scope takes 2 to 5 minutes and uses numbing jelly.
Since 2020, three FDA-approved treatments let many people keep their bladder when BCG fails. Pembrolizumab (IV every few weeks). Nadofaragene firadenovec (in the bladder every 3 months). Nogapendekin alfa with BCG (in the bladder). Removing the bladder is still on the table, especially if these stop working. Ask about all four options.
The data on lowering recurrence by quitting is mixed. The heart, lung, and second-cancer benefits are clear. Medicine plus counseling roughly doubles the odds of still being smoke-free at one year.
A missed scope gives a new tumor time to grow. Put the next year of appointments on your calendar.
You see pink or red urine between visits. Call, even if it stops by itself. Do not wait for the next scope.
For CIS, high-grade T1, or BCG-unresponsive disease, ask about a second opinion. A center that treats a lot of bladder cancer is a good place to get one. New drugs keep coming.
You cannot urinate at all (acute retention). You see heavy blood with clots you cannot pass. Your temperature goes over 100.4 F with shaking chills, especially after a BCG dose. Severe belly or flank pain comes with a fever. You feel very unwell after a BCG dose, with a fast heart rate or low blood pressure.
About this information
This is general educational information, not medical advice. It gives a plain-language summary of a condition and its common tests and treatments. The summary is not complete and cannot cover every symptom, medication, side effect, or risk that may apply to you. It is not a substitute for the judgment of a licensed clinician who has examined you and knows your history.
Reading this does not create a doctor-patient relationship with WellPrept or with any clinician who reviewed it. Always talk with your own doctor or care team before you start, stop, or change any test, treatment, or medication. If you think you have a medical emergency, call your local emergency number now.
WellPrept does not endorse any specific test, treatment, or medication as safe or effective for you. To the fullest extent allowed by law, WellPrept and its reviewers make no warranties about this information and are not liable for any decision or action based on it.
© 2026 WellPrept, Inc. All rights reserved.